MedTrace Logo

Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer

NCT02137694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2017-01-12

No results posted yet for this study

Summary

Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .

Conditions

  • Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test

Interventions

OTHER

vaginal auto-takings and urinary test

vaginal auto-takings and urinary test

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Christopher PAYAN, PU-PH · CHRU Brest

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-10-31
Completion
2016-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137694 on ClinicalTrials.gov